Explain this page
Arphra AIPlain-English read on GeneDx Holdings Corp.’s valuationBusiness description
· company · SEC profileGeneDx Holdings Corp.
GeneDx Holdings Corp., through its subsidiaries, provides genomics-related diagnostic and information services. The company offers Centrellis, an AI-driven health intelligence platform that integrates digital tools and artificial intelligence allowing scientists to ingest and synthesize clinical and genomic data to deliver comprehensive health insights. It provides genetic diagnostic tests, screening solutions, and information with a focus on pediatrics, rare diseases for children and adults, and hereditary cancer screening. GeneDx Holdings Corp. was founded in 2017 and is headquartered in Stamford, Connecticut.
Founded
—
IPO
Jul 23, 2021
Employees
1,000
HQ
Stamford, DE
CEO
Katherine A. Stueland
CFO
—
Exchange
NASDAQ
Fiscal year
—
Identifiers
· company_identifiersCIK0001818331
CUSIP81663L119
ISINUS81663L1199
FIGIWGSWW US
LEI—